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The COVID-19 pandemic has rapidly and dramati-
cally altered the programming landscape for sex-
ual and reproductive health (SRH) care. Frontline
service delivery capacity has been threatened
since the March 2020 declaration of a global pan-
demic. Like many providers, our organisation,
Marie Stopes International (MSI), one of the world’s
largest non-governmental SRH care providers, is
rapidly evolving its service delivery models to
respond. This perspective is built from the experi-
ence of the authors, who head the evidence, mar-
keting and global operations divisions in MSI, and
of our staff, with information gathered from situa-
tional analysis tracking, internal communications,
working groups, and meetings across the 37
country programmes where we operate.
A growing number of reports from frontline ser-
vice delivery organisations indicate that the supply
and provision of contraception, abortion, post-
abortion care and wider sexual health services is
being heavily affected by COVID-19.1,2 In our own
experience, this is affecting multiple service deliv-
ery channels. In several countries, our static clinics
were forced to close due to strict lockdowns, and
most are operating on reduced hours. In some
countries, like Bangladesh, India, Nepal, and Zim-
babwe, strict lockdowns are easing; in others, there
is optimism that services can resume as govern-
ments recognise contraception and abortion ser-
vices as essential. Many donor-funded
international SRH programmes use mobile out-
reach to deliver free contraception in remote
rural or under-served urban locations. Ours have
either been suspended (due to travel restrictions
or fear of coronavirus transmission, from providers
to clients, or vice versa), or teams have had to dras-
tically reduce their geographical coverage. Some
have been limited to delivering care in larger,
more urban, static health facilities; and others
have had to cease delivery of permanent and
long-acting contraceptives. The pandemic is also
affecting provision of technical assistance by inter-
national organisations to the public sector:
internal travel restrictions limit training and qual-
ity assurance work, and in several countries where
we operate, primary care providers have needed to
refocus on COVID-19 response or limit contact with
clients. We have also observed declining client
numbers across all channels, due to inaccessibility,
reduced community engagement, or fears of infec-
tion. In some instances, the latter has increased
stigma towards health care providers and against
clients.
Helped by flexible donors, service delivery
organisations can adapt, although programme
pivots are unlikely to compensate for the over-
whelmingly negative impact of the pandemic on
SRH services. Rapid adaptations that we have
been able to make include physical distancing pol-
icies (for example through the introduction of
appointment systems in clinics), enhanced infec-
tion prevention, and repurposing of community
engagement or health promotion activities to deli-
ver accurate COVID-19 information and SRH infor-
mation. Marie Stopes Uganda, for example, is
helping district health offices to share national
infection prevention information using mega-
phones and door-to-door visits. Traditional face-
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to-face engagement is also being replaced by com-
munity radio messages and social media: in many
countries, we are now using Facebook Messenger
and WhatsApp at scale to deliver information on
availability of SRH services. Some programmes
report that where SRH messaging is supplemented
with COVID-19 messaging and reassurance of the
safety of health services, we are seeing higher
uptake of family planning services.
The crisis presents an opportunity for rapid
regulatory change and programme innovation.
Several countries are now allowing wider use of
telemedicine to provide medical abortion at
home: in the UK, for example, both MSI and
the British Pregnancy Advisory Service (BPAS)
rapidly implemented this model following a
long-awaited legal change on the 30th March.3,4
While the model has been successfully adopted
in its first weeks (nearly half of MSI-UK’s abor-
tions were delivered “at home” between 14th
April and 10th May 2020), the ability of other
countries to implement similar remote services
may be constrained by shortcomings of political
will, regulation, finances, and weak infrastruc-
ture. Nevertheless, the crisis is spurring change;
for example, our programmes in Ghana, South
Africa, Ethiopia and Mexico are hopeful that
this can become a viable service in these contexts
in the upcoming weeks and months.
SRH organisations are also playing an important
role in supporting self-use of SRH products, since
pharmacy remains an important point of access
for many women. In MSI’s case, we are working
with our contact centre network in 28 countries
(who deliver counselling and advice via phone,
SMS, WhatsApp, Facebook), to increase agent
capacity, fast-track implementation of client
relationship management systems, and to offer
expanded information and counselling on
COVID-19. These contact centres are also providing
referral services and reassurance that personal pro-
tective equipment (PPE) and triage systems are in
operation, thus helping clients to overcome grow-
ing fear and distrust of healthcare workers. Whats-
App and phone are also being used to provide
remote supportive supervision, or capacity build-
ing to public and private providers, where pre-
viously technical assistance was delivered in
person. Partnerships are also proving crucial: in
Nepal, we have worked with ambulances services
and local foundations installing hand-washing
stations to transport medical abortion stock to
pharmacies in remote locations.
Despite these innovations, the challenges of
rapid programme adaptation in the current con-
text cannot be overstated. Global supply chains
for SRH commodities have been severely dis-
rupted, due to combinations of manufacturing
shut-downs and import delays.5 We have also
observed major operational and managerial chal-
lenges: for example, significant numbers of both
support and frontline staff have been unable to
work, due to movement restrictions, illness, family
demands or inability to work remotely in settings
with poor internet connectivity. The crisis also
threatens financial sustainability: for example,
some of our programmes have experienced cash
flow shortages due to reduced banking availability,
reductions in client numbers, loss of income in fee-
paying sites, and the need to redirect budgeted
resources to purchase PPE equipment or buffer
stocks. As global demand for PPE surges, procure-
ment of adequate PPE stocks is also increasingly
challenging.
But perhaps most importantly, movement and
travel restrictions are impacting upon the ability
of frontline providers to reach the most vulnerable
with SRH services. Donor-funded SRH programmes
often focus their delivery in poor, rural, margina-
lised communities – but when mobile outreach
programmes are suspended or heavily restricted,
women and girls in these areas may be left with
no alternatives; they are the least likely to access
or be able to pay for pharmacy-supplied products,
to access any form of telemedicine or to be able to
travel further to towns to find care. The flexibility
to pivot towards self-care and telemedicine is
also limited by national policy restrictions and
lack of regulatory approvals in many countries
(for example where medical abortion or injectable
contraceptives for self-administration are not
approved). The distribution and sale of products
through pharmacies is also limited during the pan-
demic: travel restrictions, reduced priority
assigned to RH products by distributors and phar-
macists, tight credit and loss of income, are some
of the factors that are making it difficult to main-
tain recent stock levels. Partnerships with online
pharmacy retailers may be one additional means
of distribution, although use will be limited to
those with internet access. And despite intensive
efforts to adapt quickly, we anticipate that reduced
access to RH services and products will have major
health consequences and disproportionately affect
the most marginalised groups that we aim to serve.
We are monitoring our programmes weekly and
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our most conservative estimates of the impact of
service reductions between March and August
2020 suggest that we could see an additional 1.3
million unintended pregnancies in the 37
countries where we work this year.6,7 We estimate
that this increased scale of unintended pregnan-
cies could mean an additional 1.2 million unsafe
abortions and 5000 pregnancy-related deaths.
Our forecast, based on 37 countries, will likely be
greatly amplified if public sector SRH services falter
across the Global South, as recent estimates from
the Guttmacher Institute suggest.8 Thus, while
the impact of COVID-19 is evidenced daily through
reported infections and deaths, the true scale of its
wider impact on SRH outcomes across the globe
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